Genomic testing for pancreatic cancer in clinical practice as real-world evidence

Precision medicine guided by comprehensive genome sequencing represents a potential treatment strategy for pancreatic cancer. However, clinical sequencing for pancreatic cancer entails several practical difficulties. We have launched an in-house clinical sequencing system and started genomic testing...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.] 2018-09, Vol.18 (6), p.647-654
Hauptverfasser:	Hayashi, Hideyuki, Tanishima, Shigeki, Fujii, Kyoko, Mori, Ryo, Okamura, Yasunobu, Yanagita, Emmy, Matsuoka, Ryosuke, Amano, Toraji, Kinoshita, Ichiro, Komatsu, Yoshito, Dosaka-Akita, Hirotoshi, Nishihara, Hiroshi
Format:	Artikel
Sprache:	eng
Schlagworte:	Age Aged Aged, 80 and over Biopsy Cancer therapies Clinical medicine Clinical sequencing Clinical trials Deoxyribonucleic acid DNA DNA, Neoplasm - blood Early Diagnosis Endpoint Determination Evidence-Based Medicine Female Gene alterations Genes Genes, Neoplasm - drug effects Genes, Neoplasm - genetics Genetic counseling Genetic Testing - methods Genomes Genomics - methods Hospitals Humans Kinases Laboratories Larynx Leukocytes (mononuclear) Male Medicine Metastasis Micronucleus, Germline Middle Aged Monocytes - chemistry Mutation Neoplasm Staging Pancreatic cancer Pancreatic Neoplasms - diagnosis Pancreatic Neoplasms - genetics Pancreatic Neoplasms - pathology Patients Peripheral blood mononuclear cells Precision Medicine Retrospective Studies Survival Analysis Therapeutic applications Treatment Outcome Turnaround time
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!